208 related articles for article (PubMed ID: 28066715)
1. Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma.
Ricker CA; Pan Y; Gutmann DH; Keller C
Front Oncol; 2016; 6():259. PubMed ID: 28066715
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas.
Helfferich J; Nijmeijer R; Brouwer OF; Boon M; Fock A; Hoving EW; Meijer L; den Dunnen WF; de Bont ES
Crit Rev Oncol Hematol; 2016 Aug; 104():30-41. PubMed ID: 27263935
[TBL] [Abstract][Full Text] [Related]
3. Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).
Fisher MJ; Jones DTW; Li Y; Guo X; Sonawane PS; Waanders AJ; Phillips JJ; Weiss WA; Resnick AC; Gosline S; Banerjee J; Guinney J; Gnekow A; Kandels D; Foreman NK; Korshunov A; Ryzhova M; Massimi L; Gururangan S; Kieran MW; Wang Z; Fouladi M; Sato M; Øra I; Holm S; Markham SJ; Beck P; Jäger N; Wittmann A; Sommerkamp AC; Sahm F; Pfister SM; Gutmann DH
Acta Neuropathol; 2021 Apr; 141(4):605-617. PubMed ID: 33585982
[TBL] [Abstract][Full Text] [Related]
4. Optic Pathway Gliomas in Neurofibromatosis Type 1.
Campen CJ; Gutmann DH
J Child Neurol; 2018 Jan; 33(1):73-81. PubMed ID: 29246098
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis type 1 and optic pathway glioma: Molecular interplay and therapeutic insights.
Khatua S; Gutmann DH; Packer RJ
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29049847
[TBL] [Abstract][Full Text] [Related]
6. Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling.
Anastasaki C; Chatterjee J; Cobb O; Sanapala S; Scheaffer SM; De Andrade Costa A; Wilson AF; Kernan CM; Zafar AH; Ge X; Garbow JR; Rodriguez FJ; Gutmann DH
Acta Neuropathol Commun; 2022 Aug; 10(1):120. PubMed ID: 35986378
[TBL] [Abstract][Full Text] [Related]
7. Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference.
Packer RJ; Iavarone A; Jones DTW; Blakeley JO; Bouffet E; Fisher MJ; Hwang E; Hawkins C; Kilburn L; MacDonald T; Pfister SM; Rood B; Rodriguez FJ; Tabori U; Ramaswamy V; Zhu Y; Fangusaro J; Johnston SA; Gutmann DH
Neuro Oncol; 2020 Jun; 22(6):773-784. PubMed ID: 32055852
[TBL] [Abstract][Full Text] [Related]
8. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
[TBL] [Abstract][Full Text] [Related]
9. Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions.
Kotch C; de Blank P; Gutmann DH; Fisher MJ
Childs Nerv Syst; 2024 May; ():. PubMed ID: 38704493
[TBL] [Abstract][Full Text] [Related]
10. Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia.
Guo X; Pan Y; Gutmann DH
Neuro Oncol; 2019 Oct; 21(10):1250-1262. PubMed ID: 31111915
[TBL] [Abstract][Full Text] [Related]
11. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
Freret ME; Gutmann DH
J Neurosci Res; 2019 Jan; 97(1):45-56. PubMed ID: 29704429
[TBL] [Abstract][Full Text] [Related]
12. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.
Ater JL; Xia C; Mazewski CM; Booth TN; Freyer DR; Packer RJ; Sposto R; Vezina G; Pollack IF
Cancer; 2016 Jun; 122(12):1928-36. PubMed ID: 27061921
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
[TBL] [Abstract][Full Text] [Related]
14. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Fangusaro J; Onar-Thomas A; Young Poussaint T; Wu S; Ligon AH; Lindeman N; Banerjee A; Packer RJ; Kilburn LB; Goldman S; Pollack IF; Qaddoumi I; Jakacki RI; Fisher PG; Dhall G; Baxter P; Kreissman SG; Stewart CF; Jones DTW; Pfister SM; Vezina G; Stern JS; Panigrahy A; Patay Z; Tamrazi B; Jones JY; Haque SS; Enterline DS; Cha S; Fisher MJ; Doyle LA; Smith M; Dunkel IJ; Fouladi M
Lancet Oncol; 2019 Jul; 20(7):1011-1022. PubMed ID: 31151904
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
[TBL] [Abstract][Full Text] [Related]
16. RNA sequence analysis reveals ITGAL/CD11A as a stromal regulator of murine low-grade glioma growth.
De Andrade Costa A; Chatterjee J; Cobb O; Sanapala S; Scheaffer S; Guo X; Dahiya S; Gutmann DH
Neuro Oncol; 2022 Jan; 24(1):14-26. PubMed ID: 34043012
[TBL] [Abstract][Full Text] [Related]
17. The molecular and cell biology of pediatric low-grade gliomas.
Chen YH; Gutmann DH
Oncogene; 2014 Apr; 33(16):2019-26. PubMed ID: 23624918
[TBL] [Abstract][Full Text] [Related]
18. Brain tumors in Neurofibromatosis type 1.
Costa AA; Gutmann DH
Neurooncol Adv; 2019; 1(1):vdz040. PubMed ID: 32642668
[TBL] [Abstract][Full Text] [Related]
19. No aberrant methylation of neurofibromatosis 1 gene (NF1) promoter in pilocytic astrocytoma in childhood.
Ebinger M; Senf L; Wachowski O; Scheurlen W
Pediatr Hematol Oncol; 2005; 22(1):83-7. PubMed ID: 15770836
[TBL] [Abstract][Full Text] [Related]
20.
Pattwell SS; Konnick EQ; Liu YJ; Yoda RA; Sekhar LN; Cimino PJ
Case Rep Pathol; 2020; 2020():5903863. PubMed ID: 32082673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
